Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8216731 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 29 Pages |
Abstract
SABR for metastatic lung tumors appears to be safe and effective with excellent local control, treatment-free intervals, and OS. An exception is metastases from colorectal cancer, which have a high LF rate consistent with a radioresistant phenotype, suggesting a potential role for dose escalation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michael S. BA, Nicholas MD, PhD, Lisa Rose BA, Rie MS, Quynh-Thu MD, Peter G. PhD, Billy W. MD, PhD, David Benjamin MD, PhD, Maximilian MD, PhD,